Partnerships in oncology drug development

This webinar will explore the value of sponsor-CRO partnerships focused on the development of oncology molecules, both from the sponsor and CRO perspective. Presenters will explore the rationale for establishing oncology clinical service alliances, challenges inherent in such relationships, and factors critical to success. Topics addressed include:

• Unique oncology drug-development factors driving the need for clinical service alliances

• Key considerations for establishing an oncology clinical service alliance, in established markets and emerging markets

• The role of risk sharing in oncology clinical service alliances

• Keys to successful governance and execution of an oncology clinical service alliance

• Benefits driven to sponsor and CRO through oncology clinical service alliances

Date: November 17, 2011
Time: 1:30PM CT | 2:30PM ET
Webcast Duration: 60 minutes


Speaker:

Coreen Oei, Ph.D.


Coreen Oei, Ph.D.
Senior VP, Clinical Operations and Project Management
BeiGene
For more information about our speaker, please click here


Nicholas Kenny, Ph.D.


Nicholas Kenny, Ph.D.
Executive VP, Oncology
INC Research
For more information about our speaker, please click here


Tim Dietlin


Tim Dietlin
VP, Alliance Development
INC Research
For more information about our speaker, please click here


Moderator:

Christiane Truelove


Christiane Truelove
Editor in chief
Med Ad News and R&D Directions

 

Sponsored by: